Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll CCR5 antagonists: host-targeted antiviral agents for the treatment of HIV infection, 4 years on Westby M; van der Ryst EAntivir Chem Chemother 2010[Apr]; 20 (5): 179-92The chemokine coreceptor 5 (CCR5) antagonists are antiretroviral agents with an extracellular, host-targeted mechanism of action against HIV. Maraviroc, the first-in-class CCR5 antagonist, received regulatory approval in 2007, becoming the first oral antiretroviral from a new class in more than 10 years. Other compounds in this class are in various stages of clinical development. In 2005, we reviewed the limited clinical data then available on CCR5 antagonists. In this follow-up review, we revisit the field and assess the clinical and virological data that have emerged in the 4 years since, with particular reference to maraviroc for which the most comprehensive data currently exist.|*CCR5 Receptor Antagonists[MESH]|Amino Acid Sequence[MESH]|Animals[MESH]|Anti-HIV Agents/adverse effects/immunology/*pharmacology/*therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Drug Resistance, Viral[MESH]|Drug-Related Side Effects and Adverse Reactions[MESH]|HIV Infections/*drug therapy/immunology/*metabolism[MESH]|Humans[MESH]|Molecular Sequence Data[MESH] |